A detailed history of Orion Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Orion Capital Management LLC holds 1,440 shares of LLY stock, worth $1.3 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
1,440
Previous 1,584 9.09%
Holding current value
$1.3 Million
Previous $923,000 21.34%
% of portfolio
0.61%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $85,276 - $114,088
-144 Reduced 9.09%
1,440 $1.12 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $131,297 - $154,782
250 Added 18.74%
1,584 $923,000
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $111,492 - $130,908
400 Added 42.83%
1,334 $433,000
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $31,448 - $39,082
134 Added 16.75%
934 $267,000
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $179,880 - $223,232
800 New
800 $221,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Orion Capital Management LLC Portfolio

Follow Orion Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Capital Management LLC with notifications on news.